BR0317748A - Composto, composição farmacêutica, e,uso de um composto - Google Patents

Composto, composição farmacêutica, e,uso de um composto

Info

Publication number
BR0317748A
BR0317748A BR0317748-3A BR0317748A BR0317748A BR 0317748 A BR0317748 A BR 0317748A BR 0317748 A BR0317748 A BR 0317748A BR 0317748 A BR0317748 A BR 0317748A
Authority
BR
Brazil
Prior art keywords
compound
pharmaceutical composition
pharmaceutically acceptable
general formula
acceptable salts
Prior art date
Application number
BR0317748-3A
Other languages
English (en)
Portuguese (pt)
Inventor
Mario Rottlonder
Ritzen Andreas
Morten Bang Norgaard
Nikolay Khanzhin
Christian Wenzel Tornoe
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35295526&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR0317748(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Priority claimed from PCT/DK2003/000906 external-priority patent/WO2004058739A1/en
Publication of BR0317748A publication Critical patent/BR0317748A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/28—Halogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30—Hetero atoms other than halogen
    • C07D333/32—Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR0317748-3A 2002-12-27 2003-12-18 Composto, composição farmacêutica, e,uso de um composto BR0317748A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200202012 2002-12-27
PCT/DK2003/000906 WO2004058739A1 (en) 2002-12-27 2003-12-18 1,2,4-triaminobenzene derivatives useful for treating disorders of the central nervous system

Publications (1)

Publication Number Publication Date
BR0317748A true BR0317748A (pt) 2005-11-22

Family

ID=35295526

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0317748-3A BR0317748A (pt) 2002-12-27 2003-12-18 Composto, composição farmacêutica, e,uso de um composto

Country Status (17)

Country Link
KR (1) KR20050089862A (uk)
CN (1) CN100448867C (uk)
AR (1) AR042656A1 (uk)
BR (1) BR0317748A (uk)
CL (1) CL2003002748A1 (uk)
EA (1) EA008589B1 (uk)
HK (1) HK1088317A1 (uk)
IS (1) IS2649B (uk)
MY (1) MY139844A (uk)
NO (1) NO20053612L (uk)
PE (1) PE20041015A1 (uk)
PL (1) PL377221A1 (uk)
SI (1) SI1578740T1 (uk)
TW (1) TWI325414B (uk)
UA (1) UA79666C2 (uk)
UY (1) UY28151A1 (uk)
ZA (1) ZA200504565B (uk)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4200259A1 (de) * 1992-01-08 1993-07-15 Asta Medica Ag Neue 1,2,4-triaminobenzol-derivate und verfahren zu deren herstellung
DE19539861A1 (de) * 1995-10-26 1997-04-30 Asta Medica Ag Verwendung von 4-Amino-4-(4-fluorbenzylamino)-1-ethoxy-carbonylaminobenzen zur Prophylaxe und Behandlung der Folgen der akuten und chronischen zerebralen Minderdurchblutung sowie neurodegenerativer Erkrankungen
GB9915414D0 (en) * 1999-07-01 1999-09-01 Glaxo Group Ltd Medical use
US6117900A (en) * 1999-09-27 2000-09-12 Asta Medica Aktiengesellschaft Use of retigabine for the treatment of neuropathic pain
US6589986B2 (en) * 2000-12-20 2003-07-08 Wyeth Methods of treating anxiety disorders

Also Published As

Publication number Publication date
PL377221A1 (pl) 2006-01-23
UY28151A1 (es) 2004-07-30
UA79666C2 (en) 2007-07-10
HK1088317A1 (en) 2006-11-03
IS7856A (is) 2005-05-23
TWI325414B (en) 2010-06-01
KR20050089862A (ko) 2005-09-08
CL2003002748A1 (es) 2005-04-08
CN100448867C (zh) 2009-01-07
ZA200504565B (en) 2006-08-30
TW200413280A (en) 2004-08-01
PE20041015A1 (es) 2005-01-08
NO20053612L (no) 2005-09-23
AR042656A1 (es) 2005-06-29
CN1732162A (zh) 2006-02-08
IS2649B (is) 2010-08-15
EA008589B1 (ru) 2007-06-29
EA200501053A1 (ru) 2005-12-29
MY139844A (en) 2009-11-30
NO20053612D0 (no) 2005-07-25
SI1578740T1 (sl) 2007-08-31

Similar Documents

Publication Publication Date Title
BRPI0408437A (pt) derivados de p-diaminobenzeno substituìdos, composição farmacêutica, e, uso da mesma
BR0108893A (pt) Composição farmacêutica, composto e processo de preparação de compostos
BR0111263A (pt) Derivados de 2-aminocarbonil-9h-purina
BR0307267A (pt) Compostos heterocìclicos, ativos como inibidores de beta-lacta-mases
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
BRPI0508570A (pt) composto, composição farmacêutica, e, uso da mesma
DK2314582T3 (da) Heterocykliske forbindelser som antivirusmidler
BRPI0413469A (pt) derivados de piperazina para o tratamento de infecções por hiv
GB0206860D0 (en) Compounds
BR0112395A (pt) Derivados de benzotiazol
BR9917080A (pt) Composto, composição farmacêutica, uso do composto e método de tratamento ou prevenção de uma disfunção tromboembólica
BRPI0212726B8 (pt) compostos contendo lactamas, e derivados dos mesmos, composição farmacêutica que os compreende e seus usos
BRPI0507818A (pt) composto e métodos de inibição
BR0206695A (pt) Formas de dosagem de epotilonas para administração oral
BRPI0213063B8 (pt) composto antibiótico de ação dupla, sua composição farmacêutica e seu uso
BR0212069A (pt) Agentes antidiabéticos orais
BRPI0409465A (pt) derivados de carboxamida como agentes antidiabéticos
BR0113590A (pt) 7-oxo-piridopirimidinas
BR9905089A (pt) Derivados macrolìdeos
BR0101230A (pt) Processo para a preparação de11-amino-3-cloro-6,11-diidro-5-5-dioxo-6-metil-dibenzo[c,f][1,2]tiazepina e aplicação para a sìntese detianeptina
BRPI0408205A (pt) derivado de anilina substituìdo, composição farmacêutica, e, uso de uma composição farmacêutica
TR200000153T2 (tr) İl-5 inhibite eden 6-azaurasil türevleri.
BR0212031A (pt) Preparados de combinação de derivados de 1,1-dióxido de 1-4-benzotiepina com outras substâncias ativas e seu emprego
BR0015333A (pt) Derivados de isoxazol como inibidores de fosfodiesterase vii
BRPI0406704A (pt) Antagonistas de 5ht~7~ e agonistas inversos

Legal Events

Date Code Title Description
B08F Application fees: dismissal - article 86 of industrial property law

Free format text: REFERENTE A 8A ANUIDADE(S).

B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2144 DE 07/02/2012.